Gates Foundation donates $150 million to push coronavirus vaccine doses below $3

The Bill & Melinda Gates Foundation is trying to make sure an eventual coronavirus vaccine is affordable for everyone.

[Aug. 7, 2020: The Week]

The Bill & Melinda Gates Foundation is trying to make sure an eventual coronavirus vaccine is affordable for everyone.

The foundation has donated $150 million to the Serum Institute of India, the world's largest vaccine maker, the Gavi vaccine alliance announced Friday. The money will help speed up the development and distribution of an eventual COVID-19 vaccine and make it available to 92 poorer countries for no more than $3 per dose.


Like these kind of stories? Get The Brighter Side of News' newsletter.


"Too many times we've seen the most vulnerable countries left at the back of the queue when it comes to new treatments, new diagnostics and new vaccines," said Gavi CEO Dr. Seth Berkley. But the consequences of such inequities when distributing a COVID-19 vaccine would be devastating. "If only the wealthiest countries in the world are protected, then international trade, commerce and society as a whole will continue to be hit hard as the pandemic continues to rage across the globe," Berkley continued.

The Serum Institute of India is one of several manufacturers working with AstraZeneca to make its candidate vaccine. It's also the go-to supplier for the World Health Organization, The Wall Street Journal notes. A total of 92 countries will be eligible to receive the discount vaccine as Gavi seeks $2 billion total to further support vaccine access..... Read More



Joseph Shavit
Joseph ShavitScience News Writer, Editor and Publisher

Joseph Shavit
Science News Writer, Editor-At-Large and Publisher

Joseph Shavit, based in Los Angeles, is a seasoned science journalist, editor and co-founder of The Brighter Side of News, where he transforms complex discoveries into clear, engaging stories for general readers. With experience at major media groups like Times Mirror and Tribune, he writes with both authority and curiosity. His work spans astronomy, physics, quantum mechanics, climate change, artificial intelligence, health, and medicine. Known for linking breakthroughs to real-world markets, he highlights how research transitions into products and industries that shape daily life.